Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K252934

    Validate with FDA (Live)

    Device Name
    Diagnocat
    Manufacturer
    Date Cleared
    2026-01-15

    (122 days)

    Product Code
    Regulation Number
    892.2070
    Age Range
    22 - 120
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Diagnocat software is a radiological, automated, concurrent read computer-assisted detection software intended to aid in the detection of periapical radiolucency on permanent teeth captured on maxillofacial Cone Beam CT images, using scans that were previously acquired for clinically justified purposes independent of Diagnocat. Diagnocat may be used only when a dental professional has independently determined that CBCT imaging is necessary for further evaluation of the patient. The device provides additional aid for the dental professional to use in their identification of periapical radiolucency. The device is not intended as a replacement for a complete dental professional's review or their clinical judgment that considers other relevant information from the patient or other images or patient history. The system is to be used by professionally trained and licensed dental professionals with the appropriate knowledge and training to interpret maxillofacial CBCT images, including at least two years of clinical experience reading and assessing CBCT scans.

    Diagnocat is indicated for use by dental professionals for the second-read of CBCT radiographs of permanent teeth in patients 22 years of age or older.

    Device Description

    Diagnocat Software is a computer-assisted detection (CADe) software-only device intended to concurrently aid in the detection of periapical radiolucency areas. The device is designed to facilitate the analysis and interpretation of previously obtained dental Cone Beam Computed Tomography (CBCT) scans, specifically in cases where a periapical radiolucency condition is suspected, leveraging deep learning algorithms and artificial intelligence (AI). The key features of the software are:

    1. Tooth Detection and Localization: Diagnocat employs image processing techniques to identify, number, and segment each tooth within a CBCT scan. The segmentation algorithm is employed to achieve tooth segmentation for tooth numeration and identification.

    2. Periapical Radiolucency and Localization: The software uses computer vision models to distinguish between normal anatomical structures and areas suspected of periapical radiolucency, which is a radiographic sign of inflammatory bone lesions at the tooth's apex. The segmentation algorithm is used for both segmentation and heat mapping of regions suspected of periapical radiolucencies.

    3. Image Visualization: Users can upload and navigate previously acquired CBCT studies. A panoramic reconstruction view aids users in navigating between a patient's teeth and identifying points of interest, and multiplanar reformatted (MPR) slices allow for detailed examination of each tooth.

    The software also features non-device functions that supplement its achievement of the intended clinical use, including a user-friendly interface, the ability to integrate with various CBCT scanning devices, and cloud-based storage to facilitate access from multiple computers.

    AI/ML Overview

    Here's a summary of the acceptance criteria and the studies proving the device's performance, based on the provided FDA 510(k) clearance letter for Diagnocat:

    1. Table of Acceptance Criteria and Reported Device Performance

    Metric/EndpointAcceptance Criteria (Pre-defined Performance Goals - PG)Diagnocat Reported Performance
    Teeth Segmentation (Mean Dice Similarity Coefficient - DSC)DSC > Desired Threshold (Implied: All DSCs exceeded the pre-defined PGs)Cohort 1 (General population): 0.955 Cohort 2 (With confirmed PARL): 0.947
    Periapical Radiolucency (PARL) Segmentation (Mean Dice Similarity Coefficient - DSC)DSC > Desired Threshold (Implied: All DSCs exceeded the pre-defined PGs)Cohort 2 (With confirmed PARL): 0.804
    PARL Detection - Sensitivity>= Desired Threshold (Implied: Met the pre-defined PGs)0.854
    PARL Detection - Specificity>= Desired Threshold (Implied: Met the pre-defined PGs)0.991
    MRMC - Improvement in AUC (Aided vs. Unaided)AUC Difference > 0 (Implied: Significant improvement)+0.027

    Studies Proving Device Meets Acceptance Criteria:

    The provided document describes three distinct studies:

    Study 1: Segmentation (Teeth and Periapical Radiolucency)

    • Sample Size for Test Set: 100 CBCT images
      • Data Provenance: Not explicitly stated (e.g., country of origin, retrospective/prospective). However, the description of "previously acquired CBCT scans" suggests a retrospective dataset.
    • Number of Experts Used for Ground Truth: Not explicitly stated.
    • Qualifications of Experts: Described as "expert radiologists." No further details on years of experience or sub-specialty are provided.
    • Adjudication Method: Not explicitly stated.
    • MRMC Comparative Effectiveness Study: No, this was a standalone performance assessment for segmentation.
    • Standalone Performance: Yes, this study assessed the algorithm's ability to segment teeth and PARL against a reference standard.
    • Type of Ground Truth Used: Reference standard established by "expert radiologists."
    • Sample Size for Training Set: Not provided.
    • How Ground Truth for Training Set Established: Not provided.

    Study 2: Detection of Periapical Radiolucency

    • Sample Size for Test Set: 285 CBCT images
      • Data Provenance: Not explicitly stated (e.g., country of origin, retrospective/prospective). Similar to Study 1, "previously acquired CBCT scans" suggests a retrospective dataset.
    • Number of Experts Used for Ground Truth: Not explicitly stated.
    • Qualifications of Experts: Described as "expert radiologists." No further details on years of experience or sub-specialty are provided.
    • Adjudication Method: Not explicitly stated.
    • MRMC Comparative Effectiveness Study: No, this was a standalone performance assessment for detection.
    • Standalone Performance: Yes, this study assessed the algorithm's ability to detect PARL against a reference standard.
    • Type of Ground Truth Used: Reference standard established by "expert radiologists."
    • Sample Size for Training Set: Not provided.
    • How Ground Truth for Training Set Established: Not provided.

    Study 3: Multi-Reader Multi-Case (MRMC)

    • Sample Size for Test Set: Not explicitly stated (the passage only refers to the "AUC" values which would be derived from a test set of cases).
      • Data Provenance: Not explicitly stated (e.g., country of origin, retrospective/prospective).
    • Number of Experts Used to Establish Ground Truth: Not explicitly stated.
    • Qualifications of Experts: Not explicitly stated for ground truth. However, the study involved "radiologist performance," implying the readers participating in the study were radiologists.
    • Adjudication Method: Not explicitly stated.
    • MRMC Comparative Effectiveness Study: Yes, "This study assessed whether the Diagnocat software improves radiologist performance in detecting PARL."
      • Effect Size of Human Readers Improvement: When aided by Diagnocat, the average Area Under the ROC Curve (AUC) increased by 0.027 compared to unaided interpretation.
    • Standalone Performance: While the algorithm's standalone performance contributes to the MRMC study, the MRMC study itself measures human performance with and without AI assistance, not the algorithm's standalone performance directly in this context (that was covered in Study 2).
    • Type of Ground Truth Used: Not explicitly stated for this study, but likely based on expert consensus for the cases used.
    • Sample Size for Training Set: Not provided.
    • How Ground Truth for Training Set Established: Not provided.

    General Notes from the document:

    • The document implies that the "reference standard established by expert radiologists" serves as the ground truth for both segmentation and detection studies.
    • The document does not explicitly detail the number of adjudicators, their specific qualifications (beyond "expert radiologists" for ground truth), or the specific adjudication rules (e.g., 2+1, 3+1).
    • Information regarding the training set's size and ground truth establishment is not provided in the summary.
    • The terms "pre-defined performance goals (PG)" are used, indicating that specific acceptance criteria were established prior to the studies, even if the exact numerical thresholds for DSC are not explicitly listed in the table provided.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1